335 related articles for article (PubMed ID: 19208735)
21. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z
Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839
[TBL] [Abstract][Full Text] [Related]
22. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx.
Gimm O
Fam Cancer; 2005; 4(1):17-23. PubMed ID: 15883706
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.
Jafri M; Whitworth J; Rattenberry E; Vialard L; Kilby G; Kumar AV; Izatt L; Lalloo F; Brennan P; Cook J; Morrison PJ; Canham N; Armstrong R; Brewer C; Tomkins S; Donaldson A; Barwell J; Cole TR; Atkinson AB; Aylwin S; Ball SG; Srirangalingam U; Chew SL; Evans DG; Hodgson SV; Irving R; Woodward E; Macdonald F; Maher ER
Clin Endocrinol (Oxf); 2013 Jun; 78(6):898-906. PubMed ID: 23072324
[TBL] [Abstract][Full Text] [Related]
24. Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.
Martucci VL; Lorenzo ZG; Weintraub M; del Rivero J; Ling A; Merino M; Siddiqui M; Shuch B; Vourganti S; Linehan WM; Agarwal PK; Pacak K
Urol Oncol; 2015 Apr; 33(4):167.e13-20. PubMed ID: 25683602
[TBL] [Abstract][Full Text] [Related]
25. Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association.
Hernandez KG; Ezzat S; Morel CF; Swallow C; Otremba M; Dickson BC; Asa SL; Mete O
Virchows Arch; 2015 Jun; 466(6):727-32. PubMed ID: 25800244
[TBL] [Abstract][Full Text] [Related]
26. [Hereditary pheochromocytoma-associated syndromes. Part 1].
Yukina MY; Troshina EA; Beltsevich DG
Ter Arkh; 2015; 87(9):102-105. PubMed ID: 26591561
[TBL] [Abstract][Full Text] [Related]
27. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
28. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.
Elder EE; Elder G; Larsson C
J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371
[TBL] [Abstract][Full Text] [Related]
29. [Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics].
Brauch H; Böhm J; Höfler H
Pathologe; 1995 Sep; 16(5):321-7. PubMed ID: 7479604
[TBL] [Abstract][Full Text] [Related]
30. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.
Fishbein L; Merrill S; Fraker DL; Cohen DL; Nathanson KL
Ann Surg Oncol; 2013 May; 20(5):1444-50. PubMed ID: 23512077
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez-Roqueplo AP; Favier J; Rustin P; Rieubland C; Crespin M; Nau V; Khau Van Kien P; Corvol P; Plouin PF; Jeunemaitre X;
Cancer Res; 2003 Sep; 63(17):5615-21. PubMed ID: 14500403
[TBL] [Abstract][Full Text] [Related]
32. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
Eisenhofer G; Lenders JW; Siegert G; Bornstein SR; Friberg P; Milosevic D; Mannelli M; Linehan WM; Adams K; Timmers HJ; Pacak K
Eur J Cancer; 2012 Jul; 48(11):1739-49. PubMed ID: 22036874
[TBL] [Abstract][Full Text] [Related]
33. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
[TBL] [Abstract][Full Text] [Related]
34. Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.
Kang HC; Kim IJ; Park JH; Shin Y; Jang SG; Ahn SA; Park HW; Lim SK; Oh SK; Kim DJ; Lee KW; Choi YS; Park YJ; Lee MR; Kim DW; Park JG
Oncol Rep; 2005 Oct; 14(4):879-83. PubMed ID: 16142346
[TBL] [Abstract][Full Text] [Related]
35. Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma.
Sue M; Martucci V; Frey F; Lenders JM; Timmers HJ; Peczkowska M; Prejbisz A; Swantje B; Bornstein SR; Arlt W; Fassnacht M; Beuschlein F; Robledo M; Pacak K; Eisenhofer G
Eur J Endocrinol; 2015 Feb; 172(2):89-95. PubMed ID: 25371406
[TBL] [Abstract][Full Text] [Related]
36. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
[TBL] [Abstract][Full Text] [Related]
37. Frequent genetic changes in childhood pheochromocytomas.
De Krijger RR; Petri BJ; Van Nederveen FH; Korpershoek E; De Herder WW; De Muinck Keizer-Schrama SM; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():166-76. PubMed ID: 17102083
[TBL] [Abstract][Full Text] [Related]
38. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Ardelt PU; Schwardt M; Schultze-Seemann W
Urol Int; 2012; 88(1):71-8. PubMed ID: 22156657
[TBL] [Abstract][Full Text] [Related]
39. Mutation screening in a Norwegian cohort with pheochromocytoma.
Sjursen W; Halvorsen H; Hofsli E; Bachke S; Berge A; Engebretsen LF; Falkmer SE; Falkmer UG; Varhaug JE
Fam Cancer; 2013 Sep; 12(3):529-35. PubMed ID: 23407919
[TBL] [Abstract][Full Text] [Related]
40. VHL disease.
Barontini M; Dahia PL
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):401-13. PubMed ID: 20833332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
